JSS Academy of Higher Education and Research

What is the placement record at JSS Academy of Higher Education and Research?

JSS Academy of Higher Education and Research (JSS AHER), Mysuru, the deemed-to-be university of JSS Mahavidyapeetha, posts its strongest placement medians in its postgraduate medical programmes: per NIRF data for academic year 2024-25 (the 2026 reporting cycle), the PG 3-year MD/MS cohort recorded a median package of Rs 19.45 LPA, while the highest packages reported across portals reach around Rs 30 LPA. As a health-sciences institution, JSS AHER's placement strength is concentrated in medicine, pharmacy and allied health rather than mass IT hiring, with most of its 1,000-plus annually placed students absorbed into hospitals, pharmaceutical majors and clinical-research firms. The university is ranked among the top 50 universities in India by NIRF and is NAAC A+ accredited, which underpins recruiter confidence across its medical, dental and pharmacy faculties.

Because JSS AHER reports placements programme-wise to NIRF rather than as a single blended figure, the most reliable way to read its record is by course family. Undergraduate medicine (MBBS, a UG 5-year programme) returned a median of Rs 13.82 LPA in the 2024-25 cycle, pharmacy programmes cluster around Rs 7.8-9.2 LPA, and the management (MBA) stream sits lower at roughly Rs 5.85 LPA. This is a research-and-clinically-driven placement profile, so an aspirant should weigh the course they are entering rather than a single headline number.

Year-Wise Placement Statistics

The table below tracks JSS AHER's placement medians across the three most recent NIRF reporting cycles - 2026 (academic year 2024-25), 2025 (academic year 2023-24) and 2024 (academic year 2022-23). Because the university discloses figures programme-wise, the "Median Package" column uses the flagship PG 3-year (MD/MS) cohort, which is JSS AHER's headline placement metric, while the "Average Package" column uses the PG 2-year median and the "% Placed" column reflects the MD/MS cohort, the most consistently reported group. Read each row as a snapshot of the same institution improving year over year, not as separate colleges.

The clear takeaway is an upward trajectory in JSS AHER's premium PG medical placements: the MD/MS median climbed from Rs 15.50 LPA (2024 cycle) to Rs 19.10 LPA (2025 cycle) and edged further to Rs 19.45 LPA in the 2026 cycle - a roughly 25% rise over two years. The PG 2-year average also moved up from Rs 10.75 LPA to Rs 11.05 LPA. For an applicant, this signals that postgraduate medicine, not undergraduate or management courses, is where JSS AHER's placement value compounds most strongly.

Programme-Wise Placement Breakdown (2026 cycle)

The next table shows how placements differ across JSS AHER's major course families in the latest 2026 (AY 2024-25) NIRF cycle, answering the practical question "which course at JSS AHER places best?" Each row lists the number of students placed and the median salary, so you can compare both volume and value. Note that pharmacy is JSS AHER's nationally ranked strength (NIRF Pharmacy rank 6 in 2024 and 2025 for the Mysuru campus) even though its medians trail PG medicine.

Two trends stand out for applicants. First, the PG 3-year MD/MS stream is JSS AHER's top-paying cohort at Rs 19.45 LPA, well ahead of every other programme. Second, pharmacy delivers high placement volume (M.Pharm placed 101 students, B.Pharm 29) at steady Rs 7.8-9.2 LPA medians - a reflection of JSS AHER's deep recruiter ties to pharmaceutical companies rather than its NIRF rank translating into the highest salaries.

Top Recruiters at JSS Academy of Higher Education and Research

JSS AHER's recruiter base mirrors its health-sciences focus, dominated by pharmaceutical manufacturers, hospital chains and clinical-research organisations rather than software firms. Verified recruiters across reputable education portals include:

Pharmaceutical & Biotech

Dr. Reddy's Laboratories, Cipla, GSK (GlaxoSmithKline), Novartis, Biocon, Himalaya, Ranbaxy and Lotus feature among the pharmaceutical and biotech recruiters that hire B.Pharm, M.Pharm and Pharm.D graduates from JSS AHER.

Hospitals & Healthcare

Apollo Hospitals, Fortis Healthcare, Phoenix and the university's own JSS Hospital are core clinical recruiters, absorbing medical, dental, nursing and allied-health graduates into roles ranging from resident doctors to clinical staff.

Clinical Research & Others

Parexel (clinical research/CRO) and Wipro also recruit from JSS AHER, the latter typically for management and allied-administrative roles. The recurring presence of these names year after year reflects long-standing institutional partnerships rather than one-off drives.

Sector & Role-Wise Breakdown

JSS AHER does not publish a single sector-wise share-of-offers table, so the picture below is drawn from its programme-wise placement volumes and recruiter profile. The dominant destination is clinical healthcare - hospitals such as Apollo, Fortis and JSS Hospital absorb the bulk of MBBS, MD/MS and dental graduates, which is why the MD/MS cohort (186 placed, Rs 19.45 LPA median) drives the university's top numbers. The second-largest sector is pharmaceuticals and biotech, where M.Pharm (101 placed) and B.Pharm (29 placed) graduates join companies like Dr. Reddy's, Cipla, Biocon and Novartis at Rs 7.8-9.2 LPA medians.

A smaller but distinct slice is clinical research and pharmacovigilance, served by recruiters such as Parexel, which hire Pharm.D and pharmacology postgraduates. Management graduates (MBA) form the smallest placement pool with a roughly 93% placement rate (54 of 58 in the 2025 cycle) but lower medians near Rs 5.85 LPA, often into healthcare administration and corporate roles. The practical reading: at JSS AHER, your sector is largely determined by your degree, and postgraduate medicine is the highest-value lane.

Placement Trend Analysis

The trajectory at JSS Academy of Higher Education and Research is one of steady, medicine-led improvement rather than dramatic swings. The clearest signal is the PG 3-year MD/MS median, which rose from Rs 15.50 LPA in the 2024 cycle to Rs 19.10 LPA in 2025 and Rs 19.45 LPA in the 2026 cycle - a sustained climb that tracks the broader premium on specialist doctors in India's expanding private-hospital sector. The MBBS (UG 5-year) median similarly inched up from around Rs 13.55 LPA to Rs 13.82 LPA across the same window, a modest but positive trend.

The reasons behind this rise are structural: JSS AHER's own JSS Hospital network and its tie-ups with Apollo, Fortis and Phoenix create a reliable clinical-placement pipeline, while its NIRF Pharmacy rank of 6 (Mysuru campus, 2024 and 2025) keeps pharmaceutical majors returning each year. The flip side an applicant should note is the spread: management and undergraduate pharmacy medians sit far below the headline MD/MS figure, so the "average" experience depends heavily on the chosen course. Overall, JSS AHER's placement record is best characterised as deep and stable within healthcare, with postgraduate medicine as its rising star.